CorEvitas HQ is a clinical research site located in Waltham, Massachusetts, United States 02451.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
CorEvitas HQ has participated in 2 clinical trials.
Therapeutic areas: Diabetic Macular Edema, Geographic Atrophy.
Sponsors: Boehringer Ingelheim.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Massachusetts · View every site in Waltham
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
CorEvitas HQ has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
CorEvitas HQ has 2 clinical trials on record. Their work covers Diabetic Macular Edema, Geographic Atrophy.
CorEvitas HQ has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.